Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-01 | 2022-10-31 | 168364 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-09-01 | 2022-10-07 | 168367 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2022-09-01 | 2022-09-16 | 168415 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-01 | 2022-09-15 | 168418 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2022-09-01 | 2022-11-20 | 168421 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-09-01 | 2022-09-23 | 168424 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2022-09-09 | 2023-09-22 | 169045 |
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-09-09 | 2022-10-14 | 169048 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2022-09-09 | 2022-10-07 | 169051 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2022-09-09 | 2022-10-14 | 169057 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-09 | 2022-09-30 | 169060 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-09-16 | 2022-09-30 | 169510 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-09-16 | 2022-11-26 | 169513 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-11-25 | 169516 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2022-09-16 | 2022-10-07 | 169519 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170106 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170109 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-09-23 | 2022-11-04 | 170112 |
| APO-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2022-09-23 | 2023-05-12 | 170115 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |